Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Andrew Hirsch — FY2025 total compensation $2,940,975

Andrew Hirsch is President and Chief Executive Officer of C4 Therapeutics, Inc. (CCCC). The company reported total compensation of $2,940,975 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$694,925
Bonus$100,000
Stock awards$710,730
Option awards$848,007
Non-equity incentive plan$573,313
Pension and non-qualified deferred compensation$0
All other compensation$14,000
Total$2,940,975

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure C4 Therapeutics, Inc. filed April 29, 2026, accession 0001628280-26-028104.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$694,925$100,000$710,730$848,007$573,313$0$14,000$2,940,975
FY2024President and Chief Executive Officer$665,000$0$755,854$3,402,805$402,325$0$13,800$5,239,784

Totals as disclosed in each year's own compensation disclosure for C4 Therapeutics, Inc..

03

Peer context

Peer-group chief executive median$4,020,142
Difference from that median$-1,079,166
Percentile within the disclosed peer group29th
Peers with a disclosed figure12

Medians and percentiles are computed across the peer group C4 Therapeutics, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of C4 Therapeutics, Inc.

Named executive officerRoleFY2025 total
Andrew Hirsch this pagePresident and Chief Executive Officer$2,940,975
Leonard ReynoChief Medical Officer$1,641,798
Kendra AdamsChief Financial Officer and Head of Corporate Affairs$1,476,789

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full C4 Therapeutics, Inc. compensation brief.

05

The company page

Andrew Hirsch's compensation sits inside C4 Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The C4 Therapeutics, Inc. (CCCC) compensation brief